• 1
    Bluestone JA. Costimulation and its role in organ transplantation. Clin Transplant 1996; 10: 104109.
  • 2
    Ingulli E, Mondino A, Khoruts A, Jenkins MK. In vivo detection of dendritic cell antigen presentation to CD4 (+) T cells. J Exp Med 1997; 185: 21332141.
  • 3
    Jenkins MK, Khoruts A, Ingulli E et al.. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19: 2345.
  • 4
    Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686688.
  • 5
    Stoll S, Delon J, Brotz TM, Germain RN. Dynamic imaging of T cell–dendritic cell interactions in lymph nodes. Science 2002; 296: 18731876.
  • 6
    Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2: 251262.
  • 7
    Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 24132417.
  • 8
    York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996; 14: 369396.
  • 9
    Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exogenous cell- associated antigen in vivo. J Exp Med 1990; 171: 377387.
  • 10
    Kievits F, Ivanyi P. A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules. J Exp Med 1991; 174: 1519.
  • 11
    Popov IA, Fedoseyeva EV, Orr PL, Garovoy MR, Benichou G. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation 1995; 60: 16211624.
  • 12
    Breur-Vriesendorp BS, Ivanyi P. Self-restricted primary human histocompatibility leukocyte antigen (HLA) -specific cytotoxic T lymphocytes. Int Immunol 1993; 5: 103107.
  • 13
    Valujskikh A, Hartig C, Heeger PS. Indirectly primed CD8+ T cells are a prominent component of the allogeneic T-cell repertoire after skin graft rejection in mice. Transplantation 2001; 71: 418421.
  • 14
    Bevan MJ. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med 1975; 142: 13491364.
  • 15
    Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976; 143: 12831288.
  • 16
    Bevan MJ. Minor H antigens introduced on H-2 different stimulating cells cross- react at the cytotoxic T cell level during in vivo priming. J Immunol 1976; 117: 22332238.
  • 17
    Bevan MJ. Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med 1995; 182: 639641.
  • 18
    Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997; 90: 15941599.
  • 19
    Sigal LJ, Crotty S, Andino R, Rock KL. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999; 398: 7780.
  • 20
    Valujskikh A, Lantz O, Celli S, Matzinger P, Heeger PS. Cross-primed CD8 (+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 2002; 3: 844851.
  • 21
    Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 2003; 197: 643656.
  • 22
    Limmer A, Ohl J, Kurts C et al.. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000; 6: 13481354.
  • 23
    Vugmeyster Y, Glas R, Perarnau B, Lemonnier FA, Eisen H, Ploegh H. Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. Proc Natl Acad Sci U S A 1998; 95: 1249212497.
  • 24
    Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352358.
  • 25
    Matesic D, Lehmann PV, Heeger PS. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65: 906914.
  • 26
    Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 2001; 166: 973981.
  • 27
    Shawar SM, Vyas JM, Rodgers JR, Rich RR. Antigen presentation by major histocompatibility complex class I-B molecules. Annu Rev Immunol 1994; 12: 839880.
  • 28
    Lindahl KF, Byers DE, Dabhi VM et al.. H2–M3, a full-service class Ib histocompatibility antigen. Annu Rev Immunol 1997; 15: 851879.
  • 29
    Tine JA, Walsh A, Rathbun D et al.. Genetic polymorphisms of Q region genes from wild-derived mice: implications for Q region evolution. Immunogenetics 1990; 31: 315325.
  • 30
    Tompkins SM, Kraft JR, Dao CT, Soloski MJ, Jensen PE. Transporters associated with antigen processing (TAP) -independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1 (b). J Exp Med 1998; 188: 961971.
  • 31
    Song R, Harding CV. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol 1996; 156: 41824190.
  • 32
    Lee RS, Grusby MJ, Laufer TM, Colvin R, Glimcher LH, Auchincloss H Jr. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of ‘major histocompatibility complex-deficient’ skin grafts. Transplantation 1997; 63: 11231133.
  • 33
    Quaini F, Urbanek K, Beltrami AP et al.. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 515.
  • 34
    Aziz S, McDonald TO, Gohra H. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. J Heart Lung Transplant 1995; 14: S123S136.
  • 35
    O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation. Transplantation 1991; 51: 438442.
  • 36
    Hillebrands J, Van Den Hurk BM, Klatter FA, Popa ER, Nieuwenhuis P, Rozing J. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. J Heart Lung Transplant 2000; 19: 11831192.